Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

Research output: Contribution to journal › Journal article › Research › peer-review

  • Daniel Grint
  • Lars Peters
  • Juergen K Rockstroh
  • Stephane de Wit
  • Victor M Mitsura
  • Brygida Knysz
  • Court Pedersen
  • Kirk, Ole
  • Lundgren, Jens
  • Amanda Mocroft
  • EuroSIDA in EuroCoord
Most antiretroviral drugs are metabolized by the liver; hepatic disease or liver damage as a result of hepatitis C virus (HCV) could impair this metabolism leading to an increased risk of drug toxicity. This study aimed to determine the risk of antiretroviral drug discontinuation among HCV/HIV coinfected patients.
Original languageEnglish
JournalAIDS (London, England)
Volume28
Issue number4
Pages (from-to)577-587
Number of pages11
DOIs
Publication statusPublished - 20 Feb 2014

ID: 105611613